Bausch + Lomb (NYSE:BLCO) is a well-known company focused on eye health, engaging in a broad range of activities aimed at improving the sight and lives of people worldwide. Its operations span across the manufacture and sale of contact lenses, surgical instruments, eye care products, and pharmaceuticals dedicated to treating a variety of eye conditions. With a rich history of innovation, Bausch + Lomb is committed to advancing the field of vision care through the development of new technologies and treatments. The company's objectives are centered on enhancing patient care and leading the industry in sustainable practices. Through ongoing research and development projects, Bausch + Lomb strives to meet the evolving needs of both eye care professionals and patients, ensuring everyone has access to the best possible eye health solutions.